Your Article Summary
See Latest ArticlesTargeting cancer cells by using an antireceptor antibody-photosensitizer fusion protein
Proceedings of the National Academy of Sciences of the United States of America, 06/10/09
Serebrovskaya EO et al. - Antibody-photosensitizer chemical conjugates are used successfully to kill cancer cells in photodynamic therapy. 4D5scFv-KillerRed showed fine targeting properties and efficiently killed p185HER-2-ECD-expressing cancer cells upon light irradiation. It also showed a remarkable additive effect with the commonly used antitumor agent cisplatin, further demonstrating the potential of the approach.
Today in Adverse Effects/Events...keeping you current
Receive free subspecialty "5-minute updates" via email
Postinjection paresthesia with articaine: a case report
Dentistry On-Line, 12/09/09
Unrecognised dural puncture resulting in subdural hygroma and cortical vein thrombosis
Anaesthesia, 12/08/09
Broken Local Anesthetic Needles
The Journal of the American Dental Association , 12/07/09